June 29 (Reuters) – Nuvox Pharma: HEALTH CANADA ALLOWS COVID-19 PATIENTS WITH RESPIRATORY FAILURE TO BE GIVEN NUVOX PHARMA’S OXYGEN THERAPEUTIC IN PHASE IIA CLINICAL…
June 29 (Reuters) – Nuvox Pharma: HEALTH CANADA ALLOWS COVID-19 PATIENTS WITH RESPIRATORY FAILURE TO BE GIVEN NUVOX PHARMA’S OXYGEN THERAPEUTIC IN PHASE IIA CLINICAL…